Review clinical trials related to Pulmonary Hypoplasia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
The purpose of this research is to gather information on the safety and effectiveness of a new procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO).
Singleton pregnancy [+5]
Multi-fetal pregnancy [+12]
Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group
Pregnant women 18 years and older, who are able to consent [+9]
Patient < 18 years of age [+16]
Congenital diaphragmatic hernia (CDH) is a birth defect characterized by the development of a hole in the diaphragm, the breathing muscle that separates the chest from the abdomen. As a result, organs in the abdomen can move into the chest and press on the developing lungs. This prevents the lungs from growing and developing normally. In severe cases, CDH can lead to serious disease and death at birth. For these babies, treatment before birth may allow the lungs to grow enough before birth so these children are capable of surviving and thriving.
Pregnant women age 18 years and older [+8]
Patient is less than 18 years of age [+16]
Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.
Isolated CDH with liver up [+12]
Patient < 18 years old [+13]